Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity

Area of Science:

• Immunology
• Pulmonology
• Cell Biology

Background:

• Allergic asthma involves airway inflammation driven by immune imbalance.
• Type 2 innate lymphoid cells (ILC2s) are key players in asthma pathogenesis.
• Mechanisms suppressing ILC2s are not well understood, despite known ILC2 activators.

Purpose of the Study:

• To investigate the role of plasmacytoid dendritic cells (pDCs) in regulating ILC2 function.
• To determine pDC influence on ILC2-mediated airway hyperreactivity (AHR) and lung inflammation.

Main Methods:

• Utilized murine models (BDCA-2-DTR transgenic, IFN-α receptor 1-deficient mice) and purified primary ILC2s.
• Extended findings to human ILC2s for validation.
• Employed transcriptomic analysis to confirm regulatory pathway activation.

Main Results:

• pDC activation via Toll-like receptor 7/8 suppresses ILC2-mediated AHR and inflammation.
• pDC depletion reverses this suppression.
• pDCs inhibit ILC2 cytokine production and proliferation while increasing apoptosis via IFN-α production.

Conclusions:

• pDC activation alleviates AHR and airway inflammation by suppressing ILC2 function and survival.
• Identified a novel regulatory pathway in ILC2-mediated pulmonary inflammation.
• Findings have significant clinical implications for managing asthma.